Invesco Dorsey Wright Healthcare Momentum ETF Rating $37.67 +0.32 (+0.86%) Closing price 03:51 PM EasternExtended Trading$37.63 -0.04 (-0.11%) As of 04:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Invesco Dorsey Wright Healthcare Momentum ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PTH Aggregate RatingModerate Buy 2.85Holdings in PTH have an aggregate rating of Moderate Buy based on 381 analyst ratings issued in the past year covering 35 companies (99.7% of the portfolio).PTH Aggregate Price Target$37.67High Prediction$37.67Average Prediction$37.67Low Prediction$37.67Holdings in PTH have an aggregate price target of $37.67 and a range of $37.67 to $37.67 covering 35 companies (99.7% of the portfolio).PTH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Dorsey Wright Healthcare Momentum ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 35 PTH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.60%CORCencora$284.40+0.0%4.2009 of 5 stars2.80$284.20 -0.1%10Positive News4.43%ALHCAlignment Healthcare$19.43+1.6%1.7098 of 5 stars2.67$16.61 -14.5%12Analyst ForecastGap Up4.03%EXELExelixis$36.54+2.2%4.2548 of 5 stars2.50$37.59 2.9%20Positive NewsGap Down3.85%LLYEli Lilly and Company$756.55+0.3%4.9192 of 5 stars2.89$1,012.00 33.8%19Analyst ForecastAnalyst Revision3.72%BSXBoston Scientific$94.19-0.1%4.4212 of 5 stars3.00$109.04 15.8%23Positive News3.66%TGTXTG Therapeutics$39.03+1.6%3.3148 of 5 stars2.83$40.67 4.2%6Positive News3.53%KRYSKrystal Biotech$169.13+0.1%4.6457 of 5 stars3.00$220.00 30.1%83.41%MDGLMadrigal Pharmaceuticals$321.10-0.4%4.0481 of 5 stars2.80$378.44 17.9%10News CoveragePositive News3.39%GHGuardant Health$44.85-0.7%3.6829 of 5 stars3.05$49.00 9.3%213.31%BBIOBridgeBio Pharma$34.24-1.8%4.5723 of 5 stars2.92$53.00 54.8%12Analyst ForecastPositive News3.27%RMDResMed$213.98-0.3%4.4085 of 5 stars2.67$249.73 16.7%15Analyst RevisionPositive News3.22%INSMInsmed$71.07+0.1%4.1144 of 5 stars3.00$94.00 32.3%16Positive News3.18%AXSMAxsome Therapeutics$103.83+0.3%4.5244 of 5 stars3.00$169.80 63.5%16Analyst Revision3.16%MMSIMerit Medical Systems$91.96-1.4%4.4891 of 5 stars3.00$114.33 24.3%10Short Interest ↓Positive News3.15%ABBVAbbVie$176.84-1.3%4.9 of 5 stars2.85$210.71 19.2%263.14%AGLagilon health$5.54-1.2%1.0238 of 5 stars2.06$4.60 -17.0%18Analyst ForecastNews Coverage3.08%LNTHLantheus$102.78+0.6%4.3397 of 5 stars3.00$129.43 25.9%7Positive News2.73%PTGXProtagonist Therapeutics$46.95+4.3%3.8077 of 5 stars3.00$65.44 39.4%9Positive NewsHigh Trading Volume2.60%CPRXCatalyst Pharmaceuticals$23.23+1.9%4.6047 of 5 stars3.13$32.29 39.0%8Positive NewsGap Down2.56%AXGNAxoGen$15.65-2.6%2.9565 of 5 stars3.00$22.60 44.4%5Short Interest ↑News CoveragePositive News2.54%MASIMasimo$152.06-1.0%4.3886 of 5 stars2.83$194.80 28.1%6Positive NewsGap Down2.46%ARQTArcutis Biotherapeutics$13.19+1.9%3.0563 of 5 stars2.83$18.80 42.5%62.38%AMRXAmneal Pharmaceuticals$7.17-0.6%3.2075 of 5 stars3.00$10.80 50.6%5Short Interest ↑Positive News2.36%TRVITrevi Therapeutics$6.20+4.2%3.3885 of 5 stars3.30$17.56 183.3%102.32%PTCTPTC Therapeutics$46.94+4.1%3.8871 of 5 stars2.53$63.77 35.9%15Short Interest ↑Positive News2.28%HALOHalozyme Therapeutics$61.28-0.2%4.3932 of 5 stars2.60$62.78 2.4%10Positive News2.22%OCULOcular Therapeutix$7.53-0.5%3.4113 of 5 stars2.89$16.38 117.5%9Gap Down2.17%AVXLAnavex Life Sciences$9.12+3.4%3.3584 of 5 stars3.33$44.00 382.5%3Gap Down2.12%MASS908 Devices$4.45+0.7%2.7157 of 5 stars2.50$5.33 19.9%4News Coverage1.90%PHRPhreesia$23.89+0.3%3.9507 of 5 stars3.00$31.50 31.9%12Analyst Forecast1.90%XERSXeris Biopharma$4.38+5.3%4.3081 of 5 stars2.80$6.10 39.3%5Short Interest ↑News CoveragePositive NewsGap Down1.86%LQDALiquidia$13.60-1.7%2.2428 of 5 stars3.11$26.63 95.8%91.77%MLYSMineralys Therapeutics$13.88-0.3%2.5758 of 5 stars3.00$33.00 137.8%3Insider TradeShort Interest ↑Positive NewsGap Up1.74%ORGOOrganogenesis$4.32-0.2%3.7666 of 5 stars2.50$5.50 27.3%2News Coverage1.69%QUREuniQure$9.65+5.2%2.1824 of 5 stars2.82$38.80 302.1%11Short Interest ↑ This page (NASDAQ:PTH) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Dorsey Wright Healthcare Momentum ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Dorsey Wright Healthcare Momentum ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.